IP Library › Granted Patent US 11,464,792
Granted Patent B2
US 11,464,792 · App. 17/155,537 · Granted Oct 11, 2022

Phospholipid compounds and formulations

Inventors: Daniel J. Laser (San Francisco, CA); Alice Luong (San Francisco, CA); Robert G. Miotke (Gold River, CA)
Assignee: Applaud Medical, Inc.
A61K31/685A61K9/0034A61K9/167A61K9/5015A61K31/663A61K41/0028A61K47/06A61K47/26A61K47/32A61K47/544A61K47/60A61K47/6925A61P13/04C07F9/3873C07F9/405
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,792
App. No.
17/155,537
Granted
Oct 11, 2022
Kind
B2
Abstract

The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.

Claims (3)

1. A compound of Formula Ia:

or a salt, isomer, or salt of an isomer thereof.

2. A compound of Formula Ib:

Assignments (2)
CHANGE OF NAME Recorded Jul 11, 2024
From: APPLAUD MEDICAL, INC.
To: AVVIO MEDICAL, INC.
Reel/Frame 068294/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2021
From: LASER, DANIEL J.; LUONG, ALICE; MIOTKE, ROBERT G.
To: APPLAUD MEDICAL, INC.
Reel/Frame 055168/0373 →
Continuity (2)
Division 16775253 · Jan 28, 2020
Related Publication 20210236524A1 · Aug 5, 2021